Cargando…
Review of local injection of anti-TNF for perianal fistulising Crohn’s disease
BACKGROUND: Perianal fistulising Crohn’s disease (PFCD) affects a third of Crohn’s disease patients and represents a disabling phenotype with poor outcome. The anti-tumour necrosis factor alpha (TNF) therapies have been shown to maintain clinical remission in a third of patients after 1 year of trea...
Autores principales: | Adegbola, Samuel O., Sahnan, Kapil, Tozer, Philip J, Phillips, Robin KS, Faiz, Omar D, Warusavitarne, Janindra, Hart, Ailsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635080/ https://www.ncbi.nlm.nih.gov/pubmed/28900730 http://dx.doi.org/10.1007/s00384-017-2899-0 |
Ejemplares similares
-
Anti-TNF Therapy in Crohn’s Disease
por: Adegbola, Samuel O., et al.
Publicado: (2018) -
Medical and surgical management of perianal Crohn’s disease
por: Adegbola, Samuel O., et al.
Publicado: (2018) -
Developing a core outcome set for fistulising perianal Crohn’s disease
por: Sahnan, Kapil, et al.
Publicado: (2019) -
Volume assessment magnetic resonance imaging technique for monitoring perianal Crohn’s fistulas
por: Lung, Phillip F. C., et al.
Publicado: (2018) -
Emerging Data on Fistula Laser Closure (FiLaC) for the Treatment of Perianal Fistulas; Patient Selection and Outcomes
por: Adegbola, Samuel O, et al.
Publicado: (2021)